142 related articles for article (PubMed ID: 34524226)
1. Recent progress of biomarkers in oral cancers.
Liang KH; Lin YY; Chiang SH; Tsai ET; Lo WL; Wang CL; Wang TY; Sun YC; Kao SY; Wu CH; Hung KF
J Chin Med Assoc; 2021 Nov; 84(11):987-992. PubMed ID: 34524226
[TBL] [Abstract][Full Text] [Related]
2. Role of Salivary Biomarkers in Oral Cancer Detection.
Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU
Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841
[TBL] [Abstract][Full Text] [Related]
3. Application of salivary noncoding microRNAs for the diagnosis of oral cancers.
Deutsch FT; Khoury SJ; Sunwoo JB; Elliott MS; Tran NT
Head Neck; 2020 Oct; 42(10):3072-3083. PubMed ID: 32686879
[TBL] [Abstract][Full Text] [Related]
4. Identification of salivary metabolomic biomarkers for oral cancer screening.
Ishikawa S; Sugimoto M; Kitabatake K; Sugano A; Nakamura M; Kaneko M; Ota S; Hiwatari K; Enomoto A; Soga T; Tomita M; Iino M
Sci Rep; 2016 Aug; 6():31520. PubMed ID: 27539254
[TBL] [Abstract][Full Text] [Related]
5. Prevalidation of salivary biomarkers for oral cancer detection.
Elashoff D; Zhou H; Reiss J; Wang J; Xiao H; Henson B; Hu S; Arellano M; Sinha U; Le A; Messadi D; Wang M; Nabili V; Lingen M; Morris D; Randolph T; Feng Z; Akin D; Kastratovic DA; Chia D; Abemayor E; Wong DT
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):664-72. PubMed ID: 22301830
[TBL] [Abstract][Full Text] [Related]
6. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.
Yang Z; Liang X; Fu Y; Liu Y; Zheng L; Liu F; Li T; Yin X; Qiao X; Xu X
EBioMedicine; 2019 Sep; 47():44-57. PubMed ID: 31409573
[TBL] [Abstract][Full Text] [Related]
7. A non-invasive miRNA-based approach in early diagnosis and therapeutics of oral cancer.
Dar GM; Agarwal S; Kumar A; Nimisha ; Apurva ; Sharma AK; Verma R; Sattar RSA; Ahmad E; Ali A; Mahajan B; Saluja SS; Meher R
Crit Rev Oncol Hematol; 2022 Dec; 180():103850. PubMed ID: 36261117
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in oral cancer: Biomarkers with clinical potential.
Yete S; Saranath D
Oral Oncol; 2020 Nov; 110():105002. PubMed ID: 32949853
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
11. High Density of Intratumor CD45RO
Zhou C; Li J; Wu Y; Diao P; Yang J; Cheng J
J Oral Maxillofac Surg; 2019 Mar; 77(3):536-545. PubMed ID: 30395824
[TBL] [Abstract][Full Text] [Related]
12. DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.
Saintigny P; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim ES; Hong WK; Lippman SM; Mao L
Clin Cancer Res; 2009 Oct; 15(19):6284-91. PubMed ID: 19773378
[TBL] [Abstract][Full Text] [Related]
13. End Binding 1 (EB1) overexpression in oral lesions and cancer: A biomarker of tumor progression and poor prognosis.
Kumar M; Mehra S; Thakar A; Shukla NK; Roychoudhary A; Sharma MC; Ralhan R; Chauhan SS
Clin Chim Acta; 2016 Aug; 459():45-52. PubMed ID: 27208742
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer.
Cao M; Zheng L; Liu J; Dobleman T; Hu S; Go VLW; Gao G; Xiao GG
Clin Oral Investig; 2018 Mar; 22(2):571-581. PubMed ID: 29299731
[TBL] [Abstract][Full Text] [Related]
15. Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy.
Rapado-González Ó; López-López R; López-Cedrún JL; Triana-Martínez G; Muinelo-Romay L; Suárez-Cunqueiro MM
Cells; 2019 Dec; 8(12):. PubMed ID: 31861130
[TBL] [Abstract][Full Text] [Related]
16. OMICS, Oral Cancer Molecular Landscapes, and Clinical Practice.
D'Souza W; Saranath D
OMICS; 2017 Dec; 21(12):689-703. PubMed ID: 29173078
[TBL] [Abstract][Full Text] [Related]
17. Role of miRNA in cancer diagnosis, prognosis, therapy and regulation of its expression by Epstein-Barr virus and human papillomaviruses: With special reference to oral cancer.
Chawla JP; Iyer N; Soodan KS; Sharma A; Khurana SK; Priyadarshni P
Oral Oncol; 2015 Aug; 51(8):731-7. PubMed ID: 26093389
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylated ZNF582 and PAX1 genes in mouth rinse samples as biomarkers for oral dysplasia and oral cancer detection.
Cheng SJ; Chang CF; Ko HH; Lee JJ; Chen HM; Wang HJ; Lin HS; Chiang CP
Head Neck; 2018 Feb; 40(2):355-368. PubMed ID: 28960639
[TBL] [Abstract][Full Text] [Related]
19. Discovery of potential serum protein biomarkers for lymph node metastasis in oral cancer.
Chai YD; Zhang L; Yang Y; Su T; Charugundla P; Ai J; Messadi D; Wong DT; Hu S
Head Neck; 2016 Jan; 38(1):118-25. PubMed ID: 25223295
[TBL] [Abstract][Full Text] [Related]
20. Oral squamous cell carcinoma - progresses from risk assessment to treatment.
Mao L
Chin J Dent Res; 2012; 15(2):83-8. PubMed ID: 23509828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
